Backbone capability 06
IP & Commercialisation
Where does British capability stop becoming British economic value?
Proposed by UKIZ · independent · not a government designation
Why this is backbone, not a mission
The recurring British pattern is strong discovery and weak retention. The backbone question is where in the chain value leaves the country.
Research → IP → spin-out or licensing → company → capital → customer → scale. UKIZ maps each step so the leak can be located rather than assumed.
What UKIZ maps here
- Technology transfer offices
- Patents and intellectual property positions
- Commercialisation expertise and experienced operators
- Founder formation programmes
- Licensing routes
- Spin-out terms and track record
- Corporate adoption and first customers
Where relevant capability concentrates today
- Strongest where research density and experienced operators overlap; weakest where research is strong and operators are scarce.
Spin-out equity terms are frequently cited as a constraint. UKIZ treats this as reported, contested and worth testing rather than settled.
Missions that depend on this
Where this capability is needed.
Dependency is a judgement based on each mission's reported constraints, not a score. Critical means the mission is unlikely to progress without it.
- Critical01 — Life Sciences & Health Innovation
- Critical05 — Advanced Materials
- Important02 — Engineering Biology & Biomanufacturing
- Important03 — Quantum Technologies
- Important07 — Robotics & Autonomous Systems
- Relevant04 — Semiconductors, Photonics & Advanced Connectivity
- Relevant06 — Future Mobility & Advanced Manufacturing
- Relevant08 — Space & Satellite Technologies
- Relevant09 — Clean Energy Systems & Industrial Decarbonisation
- Relevant10 — Defence, Security & Dual-Use Technology
- Relevant11 — AgriTech & Future Food Systems